Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.33M | 7.54M | 6.09M | 5.57M | 5.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.74M | 14.04M | 13.47M | 12.26M | 11.63M |
| Operating Income | -14.74M | -14.04M | -13.47M | -12.26M | -11.63M |
| Income Before Tax | -13.14M | -13.07M | -12.71M | -11.67M | -11.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.14 | -13.07 | -12.71 | -11.67 | -11.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.14M | -13.07M | -12.71M | -11.67M | -11.44M |
| EBIT | -14.74M | -14.04M | -13.47M | -12.26M | -11.63M |
| EBITDA | -14.70M | -13.97M | -13.40M | -12.18M | -11.53M |
| EPS Basic | -0.31 | -0.45 | -0.57 | -0.64 | -0.73 |
| Normalized Basic EPS | -0.20 | -0.29 | -0.36 | -0.41 | -0.45 |
| EPS Diluted | -0.31 | -0.45 | -0.57 | -0.64 | -0.73 |
| Normalized Diluted EPS | -0.20 | -0.29 | -0.36 | -0.41 | -0.45 |
| Average Basic Shares Outstanding | 182.97M | 132.86M | 101.23M | 79.59M | 62.56M |
| Average Diluted Shares Outstanding | 182.97M | 132.86M | 101.23M | 79.59M | 62.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |